Although the Russian vaccine Sputnik V is estimated to be 97.6% effective by the Gamaleïa Center, the developer of the vaccine, after analyzing information from 3.8 million Russians, it has still not been approved by the European Medicines Agency (EMA. ) authorized ). This means that the vaccine is not yet officially approved for administration on European territory, even if two EU countries want to use it. In France, once the MEPs adopt the health passport, the country will not accept tourists vaccinated with Sputnik V on its territory.
On Monday at Franceinfo, the Secretary of State for European Affairs, Clément Beaune, pointed out that France will not be an exception to complying with European legislation on vaccines. “In the European legal text, it is expected that all four vaccines approved by the European Medicines Agency today will be recognized. For example, a country may add a Russian or Chinese vaccine that would not be recognized by European health authorities to allow entry into its territory. This is not the choice we are making in France, ”stressed Mr Beaune. However, these can be approved after a PCR test.
“As simple and safe as a Kalashnikov”
So far, only four Covid-19 vaccines have been approved by the EMA. These are those of the Pfizer BioNTech Laboratory, Moderna, Johnson & Johnson, and AstraZeneca. With regard to the Russian vaccine Sputnik V, the first in the world, the EMA started testing on March 4th with a view to approval in EU countries. Earlier this month, President Vladimir Putin described the vaccine developed in his country as being as effective as Kalashnikov. “As a European specialist said: as safe as a Kalashnikov. We are not the ones who said it. He was a European specialist and I think he’s right. As simple and safe as a Kalashnikov, ”said the President.